Stockreport

Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

SIENNA BIOPHARMACEUTICALS  (SNNA) 
Last sienna biopharmaceuticals earnings: 8/8 04:18 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.siennabio.com/node/5806
PDF WESTLAKE VILLAGE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced [Read more]